CHKA and neoplasm: While the use of human cancer cells in immune-suppressed mice precludes evaluating changes in tumor immune cells in these xenograft models, techniques such as mass spectrometry imaging that allow overlay of metabolomic information with immunohistochemical analysis of immune cells in human cancer tissue may expand our understanding of the role of metabolism and the relationship between Chk-α and PD-L1 in immune surveillance.